Lilly said its “Depression Hurts” ad campaign for Cymbalta is working, helping drive the drug’s gains in share of the crowded market. “Patients have told us, ‘finally, someone understands what I’m ...

The FDA has called on Eli Lilly to stop running journal ads for Cymbalta as a treatment for nerve pain caused by diabetes because the ads fail to reveal risks of the drug’s use. In a letter posted on ...

While Eli Lilly's CEO was out lobbying for drug safety, the FDA was posting a letter on its website warning the drug maker to stop making "false and misleading" claims about its antidepressant ...

INDIANAPOLIS, Indiana — The U.S. Food and Drug Administration has slapped drugmaker Eli Lilly & Co. on the wrist for making “false or misleading claims” in advertisements for Cymbalta, a drug for pain ...